What is the most likely diagnosis for a 24-year-old woman, gravida 2, para 1, at 33 weeks’ gestation, with proximal muscle weakness and hyporeflexia after treatment with terbutaline (beta-2 adrenergic agonist) for preterm labor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

Beta-adrenergic agonist medications may produce significant hypokalemia in some patients, possibly through intracellular shunting, which has the potential to produce adverse cardiovascular effects. The most likely test to confirm the diagnosis is A. Serum electrolytes 1, as the patient's symptoms of fatigue, weakness, and proximal muscle weakness of the lower extremities, along with decreased deep tendon reflexes, are consistent with hypokalemia, a known side effect of beta-adrenergic agonist medications like terbutaline.

From the Research

The most likely test to confirm the diagnosis in this case is serum electrolytes (option A). This patient is experiencing symptoms consistent with hypokalemia, a known side effect of terbutaline therapy, as reported in studies such as 2 and 3. The presentation of fatigue, weakness, and proximal muscle weakness of the lower extremities with diminished deep tendon reflexes strongly suggests an electrolyte abnormality, particularly low potassium. Terbutaline is a beta-2 adrenergic agonist used for tocolysis in preterm labor that can cause intracellular potassium shifting, leading to decreased serum potassium levels, as explained in 4 and further detailed in 5. This medication-induced hypokalemia develops rapidly, explaining why symptoms appeared just three hours after initiating high-dose terbutaline. Serum electrolyte measurement would reveal the decreased potassium level, confirming the diagnosis and guiding appropriate treatment with potassium supplementation. The other listed tests would not be as immediately useful in diagnosing this acute medication-induced condition in a previously healthy pregnant woman with a clear temporal relationship between drug administration and symptom onset. It's also worth noting that while terbutaline can be used to manage hyperkalemia in certain contexts, as discussed in 6, the scenario presented here aligns more closely with the side effect profile of terbutaline causing hypokalemia. Therefore, checking serum electrolytes is the most direct and relevant diagnostic step.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.